CLINICAL AND TOMOGRAPHIC CHARACTERISTICS OF KERATOCONUS EYES INDICATED FOR CORNEAL CROSS-LINKING
Main Article Content
Abstract
Objective: To describe the clinical characteristics and corneal parameters measured by Pentacam in keratoconus cases indicated for corneal cross-linking (CXL).
Methods: A retrospective study was conducted on 17 eyes with keratoconus from 10 patients indicated for CXL at Hanoi Eye Hospital 2 from August 2024 to August 2025. Clinical features, visual acuity, refractive status, and corneal parameters obtained from Pentacam were collected and analyzed using SPSS 20.0.
Results: The mean age was 20.8 ± 5.55 years, with the majority of cases in the 19–30 age group (70.0%). The male-to-female ratio was 1.5:1. A total of 64.7% of eyes showed no typical clinical signs. Among eyes with clinical manifestations, the common findings were Fleischer ring (35.3%) and Vogt’s striae (29.4%). The mean best-corrected visual acuity was 0.51 ± 0.43 LogMAR. A high degree of astigmatism was observed, with a mean astigmatism of -5.38 ± 4.10 D, and 76.5% of eyes having astigmatism ≥ 3 D. Tomographic parameters measured by Pentacam demonstrated marked corneal abnormalities, with a mean Kmax of 57.31 ± 9.17 D. The thinnest corneal thickness was 465.12 ± 42.98 µm. The BAD-D (Belin/Ambrosio deviation) index, which integrates anterior and posterior elevation as well as corneal thickness distribution, had a mean value of 9.43 ± 4.58, exceeding the normal threshold.
Conclusion: Keratoconus cases indicated for corneal cross-linking are predominantly observed in young individuals and often lack obvious clinical signs on examination. Diagnosis, assessment of disease progression, and evaluation of treatment outcomes should be based on a combination of multiple parameters, particularly corneal tomography indices obtained from Pentacam.
Keywords
keratoconus, corneal cross-linking, Pentacam
Article Details
References
2. Enders C, Vogel D, Dreyhaupt J, et al. Corneal cross-linking in patients with keratoconus: up to 13 years of follow-up. Graefes Arch Clin Exp Ophthalmol. 2023;261(4):1037-1043.
3. Gomes JA, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359-369.
4. Asimellis G, Kaufman EJ. Keratoconus. In: StatPearls [Internet]. StatPearls Publishing; 2024.
5. Li X, Yang H, Rabinowitz YS. Longitudinal study of keratoconus progression. Exp Eye Res. 2007;85(4):502-507.
6. Naderan M, Shoar S, Rezagholizadeh F, Zolfaghari M, Naderan M. Characteristics and associations of keratoconus patients. Contact Lens Anterior Eye. 2015;38(3):199-205.
7. Davis LJ, Schechtman KB, Wilson BS, et al. Longitudinal Changes in Visual Acuity in Keratoconus. Invest Ophthalmol Vis Sci. 2006;47(2):489-500.
8. Ferdi AC, Kandel H, Nguyen V, et al. Five-year corneal cross-linking outcomes: a Save Sight Keratoconus Registry study. Clin Experiment Ophthalmol. 2023;51(1):9-18.